FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Clinical trials for FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) explained in plain language.
Never miss a new study
Get alerted when new FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) trials appear
Sign up with your email to follow new studies for FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to plug protein leak in kidney patients
Disease control Recruiting nowThis study tests an experimental drug called EVER001 in 45 adults with three types of kidney disease (FSGS, MCD, or IgA nephropathy) that cause protein to leak into urine. Participants take the drug twice daily for a year. The main goal is to see if it safely reduces protein leve…
Matched conditions: FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Phase: PHASE2 • Sponsor: Everest Medicines (China) Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug aims to stop kidney disease relapses
Disease control Recruiting nowThis study tests a drug called BAT4406F in people with two rare kidney conditions: Minimal Change Disease and Focal Segmental Glomerulosclerosis. The goal is to see if it can reduce protein in the urine and prevent the disease from coming back. About 192 participants will receive…
Matched conditions: FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Phase: PHASE2, PHASE3 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Scientists hunt for hidden antibodies in Kids' kidney disease
Knowledge-focused Recruiting nowThis study is investigating whether certain autoantibodies, especially those targeting a protein called nephrin, play a role in nephrotic syndrome, a kidney condition that causes swelling and protein loss in urine. Researchers will analyze blood and kidney tissue from 50 children…
Matched conditions: FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Phase: NA • Sponsor: Meyer Children's Hospital IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC